Related Experiment Video
Updated: Feb 23, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Advances in paediatric gastroenterology
Paul K H Tam1, Patrick H Y Chung1, Shawn D St Peter2
1Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
Insights
Minimally invasive surgery shows promise in pediatric gastrointestinal surgery, especially for common conditions. Further research is needed for rare neonatal disorders and long-term care for survivors.
Area of Science:
- Pediatric Surgery
- Gastrointestinal Surgery
- Neonatal Surgery
Background:
- Minimally invasive surgery (MIS) is advancing in pediatric gastrointestinal surgery.
- MIS benefits are well-established for common conditions like appendicitis.
- Challenges exist in applying MIS to rare neonatal gastrointestinal disorders due to limited clinical trial data.
Purpose of the Study:
- To review recent developments in pediatric gastrointestinal surgery.
- To highlight the need for clinical evidence in rare neonatal conditions.
- To discuss future research directions, including genetics and stem-cell therapy.
Main Methods:
- Review of current literature on pediatric and neonatal gastrointestinal surgery.
- Analysis of evidence supporting minimally invasive approaches.
- Discussion of challenges and future research needs for rare diseases.
Main Results:
- Minimally invasive surgery is supported by strong evidence for common pediatric gastrointestinal issues.
- Clinical trials for rare neonatal disorders are difficult but crucial.
- Specialization and collaboration have improved outcomes for conditions like biliary atresia.
Conclusions:
- High-quality evidence is essential for advancing pediatric and neonatal gastrointestinal surgery.
- Future research should focus on rare diseases, long-term sequelae, and underlying pathogenesis.
- Genetics and stem-cell therapy offer potential for conditions like Hirschsprung's disease.
Abstract:
Recent developments in paediatric gastrointestinal surgery have focused on minimally invasive surgery, the accumulation of high-quality clinical evidence, and scientific research. The benefits of minimally invasive surgery for common disorders like appendicitis and hypertrophic pyloric stenosis are all supported by good clinical evidence. Although minimally invasive surgery has been extended to neonatal surgery, it is difficult to establish its role for neonatal disorders such as oesophageal atresia and biliary atresia through clinical trials because of the rarity of these disorders. Advances in treatments for biliary atresia and necrotising enterocolitis have been achieved through specialisation, multidisciplinary management, and multicentre collaboration in research; similarly robust clinical evidence for other rare gastrointestinal disorders is needed. As more neonates with gastrointestinal diseases survive into adulthood, their long-term sequelae will also need evidence-based multidisciplinary care. Identifying cures for long-term problems of a complex developmental anomaly such as Hirschsprung's disease will rely on unravelling its pathogenesis through genetics and the development of stem-cell therapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Gastrointestinal Motility Disorders
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

